131 related articles for article (PubMed ID: 8861723)
1. Excitotoxic lesions of the rat striatum: different responses of kynurenine pathway enzymes during ontogeny.
Ceresoli G; Fuller MS; Schwarcz R
Brain Res Dev Brain Res; 1996 Mar; 92(1):61-9. PubMed ID: 8861723
[TBL] [Abstract][Full Text] [Related]
2. Acute and chronic changes in kynurenate formation following an intrastriatal quinolinate injection in rats.
Ceresoli-Borroni G; Guidetti P; Schwarcz R
J Neural Transm (Vienna); 1999; 106(3-4):229-42. PubMed ID: 10392532
[TBL] [Abstract][Full Text] [Related]
3. Kynurenine pathway enzymes in a rat model of chronic epilepsy: immunohistochemical study of activated glial cells.
Du F; Williamson J; Bertram E; Lothman E; Okuno E; Schwarcz R
Neuroscience; 1993 Aug; 55(4):975-89. PubMed ID: 8232907
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of [5-(3)H]kynurenine in the developing rat brain in vivo: effect of intrastriatal ibotenate injections.
Ceresoli G; Guidetti P; Schwarcz R
Brain Res Dev Brain Res; 1997 May; 100(1):73-81. PubMed ID: 9174248
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of the astrocytic enzymes 3-hydroxyanthranilic acid oxygenase, kynurenine aminotransferase and glutamine synthetase in seizure-prone and non-epileptic mice.
Eastman CL; Urbańska EM; Chapman AG; Schwarcz R
Epilepsy Res; 1994 Jul; 18(3):185-94. PubMed ID: 7805640
[TBL] [Abstract][Full Text] [Related]
6. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
7. Characterization of rat brain kynurenine aminotransferases I and II.
Guidetti P; Okuno E; Schwarcz R
J Neurosci Res; 1997 Nov; 50(3):457-65. PubMed ID: 9364331
[TBL] [Abstract][Full Text] [Related]
8. 3-Hydroxyanthranilic acid oxygenase-containing astrocytic processes surround glutamate-containing axon terminals in the rat striatum.
Roberts RC; McCarthy KE; Du F; Ottersen OP; Okuno E; Schwarcz R
J Neurosci; 1995 Feb; 15(2):1150-61. PubMed ID: 7869091
[TBL] [Abstract][Full Text] [Related]
9. Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation.
Saito K; Nowak TS; Suyama K; Quearry BJ; Saito M; Crowley JS; Markey SP; Heyes MP
J Neurochem; 1993 Dec; 61(6):2061-70. PubMed ID: 8245962
[TBL] [Abstract][Full Text] [Related]
10. Quinolinic acid and kynurenic acid in the mammalian brain.
Schwarcz R; Du F
Adv Exp Med Biol; 1991; 294():185-99. PubMed ID: 1685291
[No Abstract] [Full Text] [Related]
11. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
Guidetti P; Wu HQ; Schwarcz R
Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
[TBL] [Abstract][Full Text] [Related]
12. Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid.
Miranda AF; Boegman RJ; Beninger RJ; Jhamandas K
Neuroscience; 1997 Jun; 78(4):967-75. PubMed ID: 9174065
[TBL] [Abstract][Full Text] [Related]
13. Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors.
Swartz KJ; During MJ; Freese A; Beal MF
J Neurosci; 1990 Sep; 10(9):2965-73. PubMed ID: 2168940
[TBL] [Abstract][Full Text] [Related]
14. Neural grafting in a rat model of Huntington's disease: progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting.
Isacson O; Brundin P; Gage FH; Björklund A
Neuroscience; 1985 Dec; 16(4):799-817. PubMed ID: 2936982
[TBL] [Abstract][Full Text] [Related]
15. Kynurenine pathway enzymes in brain. Properties of enzymes and regulation of quinolinic acid synthesis.
Saito K; Heyes MP
Adv Exp Med Biol; 1996; 398():485-92. PubMed ID: 8906309
[No Abstract] [Full Text] [Related]
16. Increased brain quinolinic acid production in mice infected with a hamster neurotropic measles virus.
Eastman CL; Urbańska E; Löve A; Kristensson K; Schwarcz R
Exp Neurol; 1994 Jan; 125(1):119-24. PubMed ID: 7905834
[TBL] [Abstract][Full Text] [Related]
17. Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease.
Sapko MT; Guidetti P; Yu P; Tagle DA; Pellicciari R; Schwarcz R
Exp Neurol; 2006 Jan; 197(1):31-40. PubMed ID: 16099455
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterisation of kynurenine pathway enzymes. 3-Hydroxyanthranilic-acid dioxygenase and kynurenine aminotransferase.
Cesura AM; Alberati-Giani D; Buchli R; Broger C; Köhler C; Vilbois F; Lahm HW; Heitz MP; Malherbe P
Adv Exp Med Biol; 1996; 398():477-83. PubMed ID: 8906308
[No Abstract] [Full Text] [Related]
19. Kynurenine metabolism in the rat brain in vivo. Effect of acute excitotoxic insults.
Schwarcz R; Ceresoli G; Guidetti P
Adv Exp Med Biol; 1996; 398():211-9. PubMed ID: 8906268
[No Abstract] [Full Text] [Related]
20. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
Wu HQ; Rassoulpour A; Schwarcz R
J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
